Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
Background: Diverse aberrancy in genetic background, protein profiling, and biological pathways have emerged as important factors hindering discovery of effective treatment of osteosarcoma. In a previous study, we used a proteomic approach to identify some osteosarcoma-related proteins by analysis o...
Main Authors: | Parunya Chaiyawat, Dumnoensun Pruksakorn, Prach Pipatwattana, Areerak Phanphaisarn, Pimpisa Teeyakasem, Jeerawan Klangjorhor, Jongkolnee Settakorn |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Journal of Bone Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137418303117 |
Similar Items
-
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2017-10-01) -
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2020-12-01) -
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2021-05-01) -
Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis
by: Dumnoensun Pruksakorn, et al.
Published: (2018-03-01) -
Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature
by: Dumnoensun Pruksakorn, et al.
Published: (2019-02-01)